• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money
Moneycontrol

Home » News » Business

Jan 11, 2017, 05.56 PM | Source: PTI

Lupin gets USFDA nod to market its skin cream

Lupin said in a BSE filing that it "has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the United States Food and Drug Administration (USFDA)".

Like this story, share it with millions of investors on M3

Lupin gets USFDA nod to market its skin cream

Lupin said in a BSE filing that it "has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the United States Food and Drug Administration (USFDA)".

Post Your Comments

Share Cancel

Lupin gets USFDA nod to market its skin cream
Drug major Lupin has received final approval from the US health regulator to market its Desoximetasone cream, used for treatment of skin disease, in the American market.

Lupin said in a BSE filing that it "has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the United States Food and Drug Administration (USFDA)".

The products to be marketed are generic versions of Taro's Topicort LP Emollient cream, 0.05 percent and Topicort cream, 0.25 percent, it added.

As per IMS MAT September 2016 data Topicort LP emollient cream had US sales of USD 33 million while Topicort cream had US sales of USD 17 million, Lupin said.

"Both products are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses," it added.

Lupin Ltd was trading at Rs 1,521.95 a scrip, up 2.31 percent, on BSE.

Buy, Hold, Sell ? Hear it first on M3
Lupin gets USFDA nod to market its skin cream

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login